Concepedia

Donald G. Payan

DG

124

Publications

10.9K

Citations

59

H-Index

1974

Active since

Affiliations

Rigel (United States)(Current)

Howard Hughes Medical Institute

University of California, San Francisco

Sunesis (United States)

Stanford University

Donald G. Payan is an author at Rigel (United States) specializing in medicine, immunology, and cell biology.

Top concepts

Publications per year

1974–2022

124

Publications

124

R428, a Selective Small Molecule Inhibitor of Axl Kinase, Blocks Tumor Spread and Prolongs Survival in Models of Metastatic Breast Cancer

Sacha J. Holland, Alison Pan, Christian Franci et al. · Cancer Research · 2010 · 542 citations · Full text

R406, an Orally Available Spleen Tyrosine Kinase Inhibitor Blocks Fc Receptor Signaling and Reduces Immune Complex-Mediated Inflammation

Sylvia Braselmann, Vanessa Taylor, H. Zhao et al. · Journal of Pharmacology and Experimental Therapeutics · 2006 · 508 citations

Molecular cloning, expression and potential functions of the human proteinase-activated receptor-2

Stephan Böhm, Wuyi Kong, Dieter Brömme et al. · Biochemical Journal · 1996 · 458 citations · Full text

, , +22

Luminal trypsin may regulate enterocytes through proteinase-activated receptor 2

Wuyi Kong, K. McConalogue, Lev Khitin et al. · Proceedings of the National Academy of Sciences · 1997 · 318 citations · Full text

Structure and expression of a rat agrin

Fabio Rupp, Donald G. Payan, Catherine Magill-Solc et al. · Neuron · 1991 · 307 citations

, , +9

Rows per page

1–5 of 124